Docs Show AstraZeneca Knew Of Seroquel Risks

Law360, New York (March 2, 2009, 12:00 AM EST) -- Court documents unsealed Friday indicate that AstraZeneca Pharmaceuticals LP officials were mulling concerns as long as a decade ago that the company's blockbuster anti-psychotic medication Seroquel could lead to weight gain and diabetes, with one memo lauding the project physician's “great 'smoke-and-mirrors' job!"

The documents were made public in the U.S. District Court for the Middle District of Florida after plaintiffs in a multidistrict litigation accusing AstraZeneca of failing to warn of Seroquel's potential health risks won their request to force the company to release all...
To view the full article, register now.